Continuous Transfusion Independence With Imetelstat in Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Neoplasms Relapsed/Refractory/Ineligible for Erythropoiesis-Stimulating Agents in IMerge Phase III
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
continuous transfusion independence,imetelstat,non-del,lower-risk,erythropoiesis-stimulating
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要